UNSPSC 51102876: Ambroxol/cefadroxil

This classification denotes a combination drug composed of two constituents: a mucolytic and a cephalosporin antibiotic, as more fully appears.

The first constituent, ambroxol (51162702), is an expectorant and amino-alcohol that bears the molecular formula C13H18BR2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 200168S0CL, chemically known as 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [EU/ESIS 242-500-3]; ambroxol comes in forms acefyllinate [0HM1E174TN], base, and hydrochloride [CC995ZMV90].

UNSPSC 51102876 Ambroxol/cefadroxil is a Commodity code that shows minimal alignment between its nominal scope and recent state and local solicitation activity. The code nominally identifies a specific antibiotic combination product, but recent opportunities posted under this code span disparate pharmaceutical and medical supply categories—naloxone (an opioid antagonist), safe drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, direct-to-manufacturer prescription programs, and emergency medical supplies for fire rescue operations. The issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), municipal fire services (City of Tampa), and state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The geographic spread encompasses Florida, Texas, Minnesota, and Oregon.

Recent opportunities under this code illustrate the categorization mismatch. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 (note: the posted date and response deadline are inconsistent in the source). The City of Tampa issued IFB 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a response deadline of March 13, 2026, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement issued RFP S1070000015802 through MMCAP on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026. The Texas HHS Commission issued RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription programs. The code appears to function as a catch-all for pharmaceutical and medical-supply procurement rather than as a specific product code, warranting clarification of intended scope with issuing bodies before pursuit.